news
Registration has now opened for Oxford Global’s 2nd Annual Drug Discovery USA Congress 2015
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
List view / Grid view
Drug Discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
news
Registration now open for Oxford Global’s 2nd Annual Stem Cell Congress 2015
6 July 2015 | By Oxford Global
Oxford Global Conferences are delighted to announce the 2nd Annual Stem Cell Congress with our co-located Cell & Gene Therapy is taking place on the 9th & 10th of November in London, UK..
news
Discovery could lead to a universal flu vaccine
3 July 2015 | By Victoria White
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective flu vaccines...
news
Research reveals new insights into a key antibiotic target in the fight against TB
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
news
Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
news
AYOXXA and Grünenthal complete research collaboration
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
video
The Science of Affimers
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
video
Affimers and Therapeutic Applications
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
news
Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
article
The importance of adequately triaging hits from HTS campaigns
High throughput screening (HTS) continues to be employed in drug discovery as the primary source of identifying chemical starting points for drug discovery and tool compounds for chemical biology, respectively. Although small molecule drug discovery efforts have focused largely upon enzyme, receptor and ion-channel targets, there has been an increase…
video
An Introduction to Avacta Life Sciences
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
news
SciFluor Life Sciences patented compound SF0034 highlighted in The Journal of Neuroscience
19 June 2015 | By SciFluor Life Sciences
SciFluor Life Sciences has announced that pre-clinical research demonstrating the potential effectiveness of its patented novel compound, SF0034, for treating epilepsy and preventing tinnitus was published in the peer-reviewed publication, The Journal of Neuroscience...
news
Discovery could lead to targeted melanoma therapies
18 June 2015 | By Victoria White
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a new study...
news
GSK invests $95m to launch Altius with goal of radically changing and improving medicines development
17 June 2015 | By Victoria White
GSK is making a substantial investment to launch the Altius Institute for Biomedical Sciences (Altius), an independent, non-profit research institute...
article
Human pluripotent stem cell-derived cardiomyocytes in drug discovery and development
Procedures for cardiac differentiation of human pluripotent stem cells (hPSCs) have greatly improved over the past few years. The facilitated derivation of hPSC-cardiomyocytes has enabled the thorough assessment of their physiology and manipulation of their properties. Moreover, patient-specific hPSCs generated through cellular reprogramming allow for cardiac disease modelling, discovery of…
